These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15170923)

  • 41. [Use of the the ED046 kit to analyze serum KL-6 in patients with pneumonitis].
    Kitamura S; Hiwada K; Kobayashi J; Kohno N; Kawai T; Satou A; Kasukawa R; Kawakami Y; Andou M; Nakada G; Inoue H; Itou K; Matsushima T; Ogura T; Arakawa M; Yamakido M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jun; 34(6):639-45. PubMed ID: 8741528
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Usefulness of the serum KL-6 assay in patients with hepatitis C virus.
    Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
    Intervirology; 2005; 48(6):400-4. PubMed ID: 16024944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Clinical usefulness of KL-6 as a serum marker of idiopathic interstitial pneumonia].
    Kohno N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():186-9. PubMed ID: 9216213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Lung injury and serum markers].
    Suwabe A
    Rinsho Byori; 2002 Nov; 50(11):1061-6. PubMed ID: 12491603
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis.
    Matsushita T; Hasegawa M; Hamaguchi Y; Takehara K; Sato S
    J Rheumatol; 2006 Feb; 33(2):275-84. PubMed ID: 16465658
    [TBL] [Abstract][Full Text] [Related]  

  • 46. KL-6 and surfactant proteins A and D in serum and bronchoalveolar lavage fluid in patients with acute eosinophilic pneumonia.
    Daimon T; Tajima S; Oshikawa K; Bando M; Ohno S; Sugiyama Y
    Intern Med; 2005 Aug; 44(8):811-7. PubMed ID: 16157978
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased levels of KL-6 and subsequent mortality in patients with interstitial lung diseases.
    Satoh H; Kurishima K; Ishikawa H; Ohtsuka M
    J Intern Med; 2006 Nov; 260(5):429-34. PubMed ID: 17040248
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Follow-up of serum KL-6 lung fibrosis biomarker levels in 173 patients with systemic sclerosis.
    Kumánovics G; Görbe E; Minier T; Simon D; Berki T; Czirják L
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-138-44. PubMed ID: 24773853
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Monitoring markers of disease activity for interstitial lung diseases with serum surfactant proteins A and D.
    Takahashi H; Shiratori M; Kanai A; Chiba H; Kuroki Y; Abe S
    Respirology; 2006 Jan; 11 Suppl():S51-4. PubMed ID: 16423272
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The examinations for diffuse lung diseases].
    Otake K; Suwabe A; Tominaga M
    Rinsho Byori; 2000 Dec; 48(12):1112-7. PubMed ID: 11215419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinical significance of serum surfactant proteins A and D in idiopathic interstitial pneumonia].
    Honda Y
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Dec; 34 Suppl():181-5. PubMed ID: 9216212
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum concentration of surfactant protein D in patients with systemic sclerosis: The potential marker of the interstitial lung disease severity.
    Grosicka A; Manasar A; Kucharz EJ; Kotyla PJ
    Best Pract Res Clin Rheumatol; 2018 Aug; 32(4):541-549. PubMed ID: 31174823
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic value of serum surfactant protein D level prior to transplant for the development of bronchiolitis obliterans syndrome and idiopathic pneumonia syndrome following allogeneic hematopoietic stem cell transplantation.
    Nakane T; Nakamae H; Kamoi H; Koh H; Takeoka Y; Sakamoto E; Kanashima H; Nakamae M; Ohta K; Terada Y; Koh KR; Yamane T; Hino M
    Bone Marrow Transplant; 2008 Jul; 42(1):43-9. PubMed ID: 18347569
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical significance of serum levels of matrix metalloproteinase-13 in patients with systemic sclerosis.
    Asano Y; Ihn H; Kubo M; Jinnin M; Mimura Y; Ashida R; Tamaki K
    Rheumatology (Oxford); 2006 Mar; 45(3):303-7. PubMed ID: 16278285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Serum soluble CTLA-4 levels are increased in diffuse cutaneous systemic sclerosis.
    Sato S; Fujimoto M; Hasegawa M; Komura K; Yanaba K; Hayakawa I; Matsushita T; Takehara K
    Rheumatology (Oxford); 2004 Oct; 43(10):1261-6. PubMed ID: 15266059
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum marker KL-6/MUC1 for the diagnosis and management of interstitial pneumonitis.
    Kohno N
    J Med Invest; 1999 Aug; 46(3-4):151-8. PubMed ID: 10687309
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elevated serum tumor necrosis factor-alpha levels in patients with systemic sclerosis: association with pulmonary fibrosis.
    Hasegawa M; Fujimoto M; Kikuchi K; Takehara K
    J Rheumatol; 1997 Apr; 24(4):663-5. PubMed ID: 9101498
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [The sequential changes of the serum levels of KL-6, SP-D, and DLCO were followed for a long term in a case of acute bird fancier's lung].
    Takao T; Hanehira T; Zenke Y; Shikama J; Igei H; Inoue E; Yoshizawa Y
    Arerugi; 2009 Oct; 58(10):1433-40. PubMed ID: 19901513
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Levels of surfactant proteins A and D and KL-6 are elevated in the induced sputum of chronic obstructive pulmonary disease patients: a sequential sputum analysis.
    Ishikawa N; Hattori N; Tanaka S; Horimasu Y; Haruta Y; Yokoyama A; Kohno N; Kinnula VL
    Respiration; 2011; 82(1):10-8. PubMed ID: 21474912
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elevated serum APRIL levels in patients with systemic sclerosis: distinct profiles of systemic sclerosis categorized by APRIL and BAFF.
    Matsushita T; Fujimoto M; Hasegawa M; Tanaka C; Kumada S; Ogawa F; Takehara K; Sato S
    J Rheumatol; 2007 Oct; 34(10):2056-62. PubMed ID: 17896803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.